137 related articles for article (PubMed ID: 37758026)
1. Survival of patients with basal cell carcinoma, squamous cell carcinoma, and squamous cell carcinoma in situ: A whole population study.
Sharp K; Olafsdottir EJ; Sahni DR; Madsen S; Grant-Kels JM; Kristjansson A; Hoyt DW; Ungar JP; Frigerio A; Jonasson JG; Adalsteinsson JA
J Am Acad Dermatol; 2024 Jan; 90(1):91-97. PubMed ID: 37758026
[TBL] [Abstract][Full Text] [Related]
2. Statins are associated with increased risk of squamous cell carcinoma of the skin: a whole-population study from Iceland.
Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Feng H; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
Arch Dermatol Res; 2022 Oct; 314(8):805-808. PubMed ID: 33772628
[TBL] [Abstract][Full Text] [Related]
3. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
J Am Acad Dermatol; 2021 Mar; 84(3):669-675. PubMed ID: 32791082
[TBL] [Abstract][Full Text] [Related]
4. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
[TBL] [Abstract][Full Text] [Related]
5. Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from Iceland.
Adalsteinsson JA; Muzumdar S; Waldman R; Wu R; Ratner D; Feng H; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
J Am Acad Dermatol; 2021 Jul; 85(1):56-61. PubMed ID: 33610593
[TBL] [Abstract][Full Text] [Related]
6. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.
Asgari MM; Tsai AL; Avalos L; Sokil M; Quesenberry CP
JAMA Dermatol; 2020 Oct; 156(10):1066-1073. PubMed ID: 32785626
[TBL] [Abstract][Full Text] [Related]
7. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
[TBL] [Abstract][Full Text] [Related]
8. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
9. Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study.
Keim U; van der Pols JC; Williams GM; Green AC
J Invest Dermatol; 2015 Mar; 135(3):728-733. PubMed ID: 25233075
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's Disease, Melanoma, and Keratinocyte Carcinoma: A Population-Based Study.
Lerman S; Amichai B; Weinstein G; Shalev V; Chodick G
Neuroepidemiology; 2018; 50(3-4):168-173. PubMed ID: 29566384
[TBL] [Abstract][Full Text] [Related]
11. Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies.
Tang H; Fu S; Zhai S; Song Y; Asgari MM; Han J
Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):279-288. PubMed ID: 29318704
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.
Yanik EL; Pfeiffer RM; Freedman DM; Weinstock MA; Cahoon EK; Arron ST; Chaloux M; Connolly MK; Nagarajan P; Engels EA
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):998-1007. PubMed ID: 28377416
[No Abstract] [Full Text] [Related]
13. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis.
Flohil SC; van der Leest RJ; Arends LR; de Vries E; Nijsten T
Eur J Cancer; 2013 Jul; 49(10):2365-75. PubMed ID: 23608733
[TBL] [Abstract][Full Text] [Related]
14. The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study.
Genders RE; Mazlom H; Michel A; Plasmeijer EI; Quint KD; Pawlita M; van der Meijden E; Waterboer T; de Fijter H; Claas FH; Wolterbeek R; Feltkamp MCW; Bouwes Bavinck JN
J Invest Dermatol; 2015 May; 135(5):1275-1282. PubMed ID: 25347116
[TBL] [Abstract][Full Text] [Related]
15. Forearm hair density and risk of keratinocyte cancers in Australian adults.
von Schuckmann LA; Hughes MC; Green AC; van der Pols JC
Arch Dermatol Res; 2016 Nov; 308(9):617-624. PubMed ID: 27590883
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.
Venables ZC; Nijsten T; Wong KF; Autier P; Broggio J; Deas A; Harwood CA; Hollestein LM; Langan SM; Morgan E; Proby CM; Rashbass J; Leigh IM
Br J Dermatol; 2019 Sep; 181(3):474-482. PubMed ID: 30864158
[TBL] [Abstract][Full Text] [Related]
17. Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis.
Rees JR; Zens MS; Celaya MO; Riddle BL; Karagas MR; Peacock JL
Int J Cancer; 2015 Aug; 137(4):878-884. PubMed ID: 25598534
[TBL] [Abstract][Full Text] [Related]
18. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
19. Anatomic Features of Head and Neck Keratinocyte Cancer in Virginia.
Karlin J; Engelhard S; Russell M; Kirzhner M
Dermatol Surg; 2020 Dec; 46(12):1486-1491. PubMed ID: 32205748
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship.
Wilson A; Small J; Flanagan C; Perry D; Marchell R; Thiers B; Alberg AJ
Anticancer Res; 2019 Sep; 39(9):5083-5087. PubMed ID: 31519619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]